pillbase.ru

Insulin lispro Sanofi

Active substance: Insulin Lispro

insulin lispro

Centralised EU authorisationActive

Marketing holder: Sanofi Winthrop Industrie

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 29
  • ADMELOG
    INJECTION, SOLUTION · INSULIN LISPRO 100 U/mL
    0024-5925
    Sanofi-Aventis U.S. LLC
  • ADMELOG
    INJECTION, SOLUTION · INSULIN LISPRO 100 U/mL
    70518-4275
    REMEDYREPACK INC.
  • ADMELOG
    INJECTION, SOLUTION · INSULIN LISPRO 100 U/mL
    0024-5926
    Sanofi-Aventis U.S. LLC
  • ADMELOG
    INJECTION, SOLUTION · INSULIN LISPRO 100 U/mL
    0024-5924
    Sanofi-Aventis U.S. LLC
  • HUMALOG
    INJECTION, SOLUTION · INSULIN LISPRO 100 [iU]/mL
    50090-4488
    A-S Medication Solutions
All products in this country (29)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-427b-7836-8d19-04cf7d2c1e85,01a1208c-463d-7b3f-adc6-e355bd8a2472,01a1208c-67b8-70c3-8596-8ad5f3dac872,01a1208d-d613-79f1-98b5-33816c0ef552,01a1208d-ff44-74f6-93e8-f8abbf43333e;count=29 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004303
Registration status
Active
ATC code
A10AB04
Sources
  • product · EMA · EMEA/H/C/004303 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004303 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004303 · Verified 2026-10-09